Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Ramzey Abujarour et al.|Cell stem cell|2021Cited by 153
CD45 alternative exon expression in murine and human CD4+ T cell subsetsPaul Rogers, David C. Parker, Suzie Pilapil et al.|The Journal of Immunology|1992Cited by 54
Engineered iPSC-Derived NK Cells Expressing Recombinant CD64 for Enhanced ADCCKate Dixon, Bruce Walcheck, Robert Hullsiek et al.|Blood|2020Cited by 8
Arming of iPSC-Derived NK Cells Expressing a Novel CD64 Fusion Receptor with Therapeutic Antibodies Represents a Novel Off-the-Shelf, Antigen-Targeting Strategy for CancerKate Dixon, Bruce Walcheck, Kristin M. Snyder et al.|Blood|2021Cited by 0